Dimensional Fund Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Dimensional Fund Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5.2M	Sell	100,626 -94,862	-49%	-$3.92M	﹤0.01%	2414
2022 Q2	$4.84M	Sell	195,488 -124,852	-39%	-$2.75M	﹤0.01%	2457
2022 Q1	$8.03M	Buy	320,340 +172,958	+117%	+$4.86M	﹤0.01%	2380
2021 Q4	$5.37M	Buy	147,382 +2,718	+2%	+$95.4K	﹤0.01%	2541
2021 Q3	$2.47M	Buy	144,664 +9,672	+7%	+$151K	﹤0.01%	2791
2021 Q2	$1.81M	Sell	134,992 -2,130	-2%	-$52.5K	﹤0.01%	2895
2021 Q1	$7.03M	Sell	137,122 -158,760	-54%	-$9.55M	﹤0.01%	2451
2020 Q4	$18.3M	Sell	295,882 -305,656	-51%	-$17.5M	0.01%	2020
2020 Q3	$33M	Sell	601,538 -317,642	-35%	-$17.1M	0.01%	1529
2020 Q2	$52.9M	Sell	919,180 -6,744	-0.7%	-$367K	0.02%	1154
2020 Q1	$37.2M	Sell	925,924 -46,386	-5%	-$1.97M	0.02%	1295
2019 Q4	$38.5M	Sell	972,310 -63,084	-6%	-$1.11M	0.01%	1659
2019 Q3	$7.02M	Hold	1,035,394	–	–	﹤0.01%	2484
2019 Q2	$9.63M	Sell	1,035,394 -159,596	-13%	-$1.85M	﹤0.01%	2408
2019 Q1	$16.6M	Buy	1,194,990 +562,929	+89%	+$6.44M	0.01%	2151
2018 Q4	$6.9M	Buy	632,061 +84,290	+15%	+$889K	﹤0.01%	2496
2018 Q3	$6.92M	Buy	547,771 +226,485	+70%	+$2.73M	﹤0.01%	2579
2018 Q2	$4.23M	Buy	+321,286	New	+$3.84M	﹤0.01%	2704
2015 Q1	–	Sell	-9,699	Closed	-$66K	–	3411
2014 Q4	$66K	Buy	9,699 +2,200	+29%	+$11.6K	﹤0.01%	3354
2014 Q3	$34K	Hold	7,499	–	–	﹤0.01%	3422
2014 Q2	$44K	Hold	7,499	–	–	﹤0.01%	3447
2014 Q1	$50K	Sell	7,499 -7,562	-50%	-$52.5K	﹤0.01%	3450
2013 Q4	$87K	Buy	+15,061	New	+$77.7K	﹤0.01%	3366

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

SFM

Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Dimensional Fund Advisors's CCXI Position: Q3 2022 in Review

Dimensional Fund Advisors reduced its ChemoCentryx, Inc. (CCXI) stake by 49% in Q3 2022, selling an estimated $3.92M and leaving 100,626 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2414.

Dimensional Fund Advisors first reported a position in CCXI in Q4 2013 and has held it in 23 quarters since. The position peaked at $52.9M in Q2 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Dimensional Fund Advisors held 100,626 shares of ChemoCentryx, Inc. worth $5.2M as of Q3 2022.
Dimensional Fund Advisors sold 94,862 ChemoCentryx, Inc. shares in Q3 2022, an estimated $3.92M.
ChemoCentryx, Inc. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #2414 holding.
Dimensional Fund Advisors first reported a position in ChemoCentryx, Inc. in Q4 2013 and has held it in 23 quarters since.
Dimensional Fund Advisors's ChemoCentryx, Inc. position peaked at $52.9M in Q2 2020.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.